Skip to main content
Erschienen in: Pathology & Oncology Research 3/2020

14.08.2019 | Original Article

Clinical Application of Long Non-Coding RNA-UCA1 as a Candidate Gene in Progression of Esophageal Cancer

verfasst von: Hamid Aalijahan, Saeid Ghorbian

Erschienen in: Pathology & Oncology Research | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Esophageal cancer (EC) is known as one of the most prevalent gastrointestinal cancers, and results in the seventh highest number of cancer-relevant deaths. Long non-coding RNAs (lncRNAs) have substantial roles in several biological processes. LncRNA human urothelial carcinoma associated 1 (UCA1) is announced to be enhanced in multiple types of human cancers. This survey was carried out to identify the potential role of the lncRNA-UCA1 in the progression of EC. A case-control investigation was performed on 140 FFPE tissues of EC patients consisting of 70 cancerous tissues and 70 marginal tissues samples. To determine the lncRNA-UCA1 gene expression changes, quantitative reverse-transcription polymerase chain reaction (qRT-PCR) method was utilized. In addition, the associations between the lncRNA-UCA1 gene expression and clinicopathological parameters were assessed. Our findings revealed that the lncRNA-UCA1 was notably up-regulated in EC tissues compared to adjacent normal tissues (P < 0.05). LncRNA-UCA1 expression was substantially correlated to alcohol drinking (P = 0.008) and socioeconomic status (P = 0.001), while shared no correlation with age, hot drinking status and stage (P > 0.05). Our data indicated that the lncRNA-UCA1 play an important role in the progression of EC and may be considered as a candidate gene in the pathogenesis of EC patients.
Literatur
1.
Zurück zum Zitat Zhang Y (2013 14) Epidemiology of esophageal cancer. World J Gastroenterol: WJG 19(34):5598CrossRef Zhang Y (2013 14) Epidemiology of esophageal cancer. World J Gastroenterol: WJG 19(34):5598CrossRef
2.
Zurück zum Zitat Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87–108CrossRef Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87–108CrossRef
3.
Zurück zum Zitat Ghorbian S, Ardekani AM (2012) Non-invasive detection of esophageal Cancer using genetic changes in circulating cell-free DNA. Avicenna J Med Biotechnol 4(1):3–13PubMedPubMedCentral Ghorbian S, Ardekani AM (2012) Non-invasive detection of esophageal Cancer using genetic changes in circulating cell-free DNA. Avicenna J Med Biotechnol 4(1):3–13PubMedPubMedCentral
4.
Zurück zum Zitat Song Q, Liu H, Wang J, Jia Y, Liu Y, Wang N, Tan B, Guan S, An D, Cheng Y (2014) Dinner-to-bed time and post-dinner walk: new potential independent factors in esophageal cancer development. J Cancer Res Clin Oncol 140(5):817–821CrossRef Song Q, Liu H, Wang J, Jia Y, Liu Y, Wang N, Tan B, Guan S, An D, Cheng Y (2014) Dinner-to-bed time and post-dinner walk: new potential independent factors in esophageal cancer development. J Cancer Res Clin Oncol 140(5):817–821CrossRef
5.
Zurück zum Zitat Tang WR, Fang JY, Wu KS, Shi XJ, Luo JY, Lin K (2014) Epidemiological characteristics and prediction of esophageal cancer mortality in China from 1991 to 2012. Asian Pac J Cancer Prev 15(16):6929–6934CrossRef Tang WR, Fang JY, Wu KS, Shi XJ, Luo JY, Lin K (2014) Epidemiological characteristics and prediction of esophageal cancer mortality in China from 1991 to 2012. Asian Pac J Cancer Prev 15(16):6929–6934CrossRef
6.
Zurück zum Zitat Park S, Paeng JC, Kang CH, Cheon GJ, Kang KW, Chung JK, Lee DS (2018) Dual-time point 18 F-FDG PET/CT for the staging of oesophageal cancer: the best diagnostic performance by retention index for N-staging in non-calcified lymph nodes. Eur J Nucl Med Mol Imaging:1–2 Park S, Paeng JC, Kang CH, Cheon GJ, Kang KW, Chung JK, Lee DS (2018) Dual-time point 18 F-FDG PET/CT for the staging of oesophageal cancer: the best diagnostic performance by retention index for N-staging in non-calcified lymph nodes. Eur J Nucl Med Mol Imaging:1–2
7.
Zurück zum Zitat Lanzafame M, Bianco G, Terracciano L, Ng C, Piscuoglio S (2018) The role of long non-coding RNAs in hepatocarcinogenesis. Int J Mol Sci 19(3):682CrossRef Lanzafame M, Bianco G, Terracciano L, Ng C, Piscuoglio S (2018) The role of long non-coding RNAs in hepatocarcinogenesis. Int J Mol Sci 19(3):682CrossRef
8.
Zurück zum Zitat Aalijahan H, Ghorbian S (2018) Long non-coding RNAs and cervical cancer. Exp Mol Pathol Aalijahan H, Ghorbian S (2018) Long non-coding RNAs and cervical cancer. Exp Mol Pathol
9.
Zurück zum Zitat Iyer MK, Niknafs YS, Malik R, Singhal U, Sahu A, Hosono Y, Barrette TR, Prensner JR, Evans JR, Zhao S, Poliakov A (2015) The landscape of long noncoding RNAs in the human transcriptome. Nat Genet 47(3):199–208CrossRef Iyer MK, Niknafs YS, Malik R, Singhal U, Sahu A, Hosono Y, Barrette TR, Prensner JR, Evans JR, Zhao S, Poliakov A (2015) The landscape of long noncoding RNAs in the human transcriptome. Nat Genet 47(3):199–208CrossRef
10.
Zurück zum Zitat Cabili MN, Trapnell C, Goff L, Koziol M, Tazon-Vega B, Regev A, Rinn JL (2011) Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev 2 Cabili MN, Trapnell C, Goff L, Koziol M, Tazon-Vega B, Regev A, Rinn JL (2011) Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev 2
11.
Zurück zum Zitat Martianov I, Ramadass A, Barros AS, Chow N, Akoulitchev A (2007) Repression of the human dihydrofolate reductase gene by a non-coding interfering transcript. Nature 445(7128):666–670CrossRef Martianov I, Ramadass A, Barros AS, Chow N, Akoulitchev A (2007) Repression of the human dihydrofolate reductase gene by a non-coding interfering transcript. Nature 445(7128):666–670CrossRef
12.
Zurück zum Zitat Bayoumi AS, Sayed A, Broskova Z, Teoh JP, Wilson J, Su H, Tang YL, Kim IM (2016) Crosstalk between long noncoding RNAs and microRNAs in health and disease. Int J Mol Sci 17(3):356CrossRef Bayoumi AS, Sayed A, Broskova Z, Teoh JP, Wilson J, Su H, Tang YL, Kim IM (2016) Crosstalk between long noncoding RNAs and microRNAs in health and disease. Int J Mol Sci 17(3):356CrossRef
13.
Zurück zum Zitat Wang KC, Yang YW, Liu B, Sanyal A, Corces-Zimmerman R, Chen Y, Lajoie BR, Protacio A, Flynn RA, Gupta RA, Wysocka J (2011) A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature. 472(7341):120–124CrossRef Wang KC, Yang YW, Liu B, Sanyal A, Corces-Zimmerman R, Chen Y, Lajoie BR, Protacio A, Flynn RA, Gupta RA, Wysocka J (2011) A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature. 472(7341):120–124CrossRef
14.
Zurück zum Zitat Ye H, Lin J, Yao X, Li Y, Lin X, Lu H (2018) Overexpression of long non-coding RNA NNT-AS1 correlates with tumor progression and poor prognosis in osteosarcoma. Cell Physiol Biochem 45(5):1904–1914CrossRef Ye H, Lin J, Yao X, Li Y, Lin X, Lu H (2018) Overexpression of long non-coding RNA NNT-AS1 correlates with tumor progression and poor prognosis in osteosarcoma. Cell Physiol Biochem 45(5):1904–1914CrossRef
15.
Zurück zum Zitat Xue M, Chen W, Li X (2016) Urothelial cancer associated 1: a long noncoding RNA with a crucial role in cancer. J Cancer Res Clin Oncol 142(7):1407–1419CrossRef Xue M, Chen W, Li X (2016) Urothelial cancer associated 1: a long noncoding RNA with a crucial role in cancer. J Cancer Res Clin Oncol 142(7):1407–1419CrossRef
16.
Zurück zum Zitat Liu FT, Dong Q, Gao H, Zhu ZM (2017) The prognostic significance of UCA1 for predicting clinical outcome in patients with digestive system malignancies. Oncotarget 8(25):40620CrossRef Liu FT, Dong Q, Gao H, Zhu ZM (2017) The prognostic significance of UCA1 for predicting clinical outcome in patients with digestive system malignancies. Oncotarget 8(25):40620CrossRef
17.
Zurück zum Zitat Huang J, Zhou N, Watabe K, Lu Z, Wu F, Xu M, Mo YY (2015) Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1). Cell Death Dis 5(1):e1008CrossRef Huang J, Zhou N, Watabe K, Lu Z, Wu F, Xu M, Mo YY (2015) Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1). Cell Death Dis 5(1):e1008CrossRef
18.
Zurück zum Zitat Yang YT, Wang YF, Lai JY, Shen SY, Wang F, Kong J, Zhang W, Yang HY (2016) Long non-coding RNA UCA 1 contributes to the progression of oral squamous cell carcinoma by regulating the WNT/β-catenin signaling pathway. Cancer Sci 107(11):1581–1589CrossRef Yang YT, Wang YF, Lai JY, Shen SY, Wang F, Kong J, Zhang W, Yang HY (2016) Long non-coding RNA UCA 1 contributes to the progression of oral squamous cell carcinoma by regulating the WNT/β-catenin signaling pathway. Cancer Sci 107(11):1581–1589CrossRef
19.
Zurück zum Zitat Bian Z, Jin L, Zhang J, Yin Y, Quan C, Hu Y, Feng Y, Liu H, Fei B, Mao Y, Zhou L (2016) LncRNA—UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p. Sci Rep 6:23892CrossRef Bian Z, Jin L, Zhang J, Yin Y, Quan C, Hu Y, Feng Y, Liu H, Fei B, Mao Y, Zhou L (2016) LncRNA—UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p. Sci Rep 6:23892CrossRef
20.
Zurück zum Zitat Razavi M, Ghorbian S (2019) Original article - up-regulation of long non-coding RNA-PCAT-1 promotes invasion and metastasis in esophageal squamous cell carcinoma. EXCLI 18:422–428 Razavi M, Ghorbian S (2019) Original article - up-regulation of long non-coding RNA-PCAT-1 promotes invasion and metastasis in esophageal squamous cell carcinoma. EXCLI 18:422–428
21.
Zurück zum Zitat Sadeghpour S, Ghorbian S (2019) Evaluation of the potential clinical prognostic value of lncRNA-BANCR gene in esophageal squamous cell carcinoma. Mol Biol Rep 46:991–995CrossRef Sadeghpour S, Ghorbian S (2019) Evaluation of the potential clinical prognostic value of lncRNA-BANCR gene in esophageal squamous cell carcinoma. Mol Biol Rep 46:991–995CrossRef
22.
Zurück zum Zitat Qian Y, Liu D, Cao S, Tao Y, Wei D, Li W, Li G, Pan X, Lei D (2017) Upregulation of the long noncoding RNA UCA1 affects the proliferation, invasion, and survival of hypopharyngeal carcinoma. Mol Cancer 16(1):68CrossRef Qian Y, Liu D, Cao S, Tao Y, Wei D, Li W, Li G, Pan X, Lei D (2017) Upregulation of the long noncoding RNA UCA1 affects the proliferation, invasion, and survival of hypopharyngeal carcinoma. Mol Cancer 16(1):68CrossRef
23.
Zurück zum Zitat Zhao W, Sun C, Cui Z (2017) A long noncoding RNA UCA1 promotes proliferation and predicts poor prognosis in glioma. Clin Transl Oncol 19(6):735–741CrossRef Zhao W, Sun C, Cui Z (2017) A long noncoding RNA UCA1 promotes proliferation and predicts poor prognosis in glioma. Clin Transl Oncol 19(6):735–741CrossRef
24.
Zurück zum Zitat Chen P, Wan D, Zheng D, Zheng Q, Wu F, Zhi Q (2016) Long non-coding RNA UCA1 promotes the tumorigenesis in pancreatic cancer. Biomed Pharmacother 83:1220–1226CrossRef Chen P, Wan D, Zheng D, Zheng Q, Wu F, Zhi Q (2016) Long non-coding RNA UCA1 promotes the tumorigenesis in pancreatic cancer. Biomed Pharmacother 83:1220–1226CrossRef
25.
Zurück zum Zitat Wang HM, Lu JH, Chen WY, Gu AQ (2015) Upregulated lncRNA-UCA1 contributes to progression of lung cancer and is closely related to clinical diagnosis as a predictive biomarker in plasma. Int J Clin Exp Med 8(7):11824PubMedPubMedCentral Wang HM, Lu JH, Chen WY, Gu AQ (2015) Upregulated lncRNA-UCA1 contributes to progression of lung cancer and is closely related to clinical diagnosis as a predictive biomarker in plasma. Int J Clin Exp Med 8(7):11824PubMedPubMedCentral
26.
Zurück zum Zitat Fang Z, Wu L, Wang L, Yang Y, Meng Y, Yang H (2014) Increased expression of the long non-coding RNA UCA1 in tongue squamous cell carcinomas: a possible correlation with cancer metastasis. Oral Surg Oral Med Oral Pathol Oral Radiol 117(1):89–95CrossRef Fang Z, Wu L, Wang L, Yang Y, Meng Y, Yang H (2014) Increased expression of the long non-coding RNA UCA1 in tongue squamous cell carcinomas: a possible correlation with cancer metastasis. Oral Surg Oral Med Oral Pathol Oral Radiol 117(1):89–95CrossRef
27.
Zurück zum Zitat Huang J, Zhou N, Watabe K, Lu Z, Wu F, Xu M, Mo YY (2015) Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1). Cell Death Dis 5(1):e1008CrossRef Huang J, Zhou N, Watabe K, Lu Z, Wu F, Xu M, Mo YY (2015) Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1). Cell Death Dis 5(1):e1008CrossRef
28.
Zurück zum Zitat Han Y, Yang YN, Yuan HH, Zhang TT, Sui H, Wei XL, Liu L, Huang P, Zhang WJ, Bai YX (2014) UCA1, a long non-coding RNA up-regulated in colorectal cancer influences cell proliferation, apoptosis and cell cycle distribution. Pathology. 46(5):396–401CrossRef Han Y, Yang YN, Yuan HH, Zhang TT, Sui H, Wei XL, Liu L, Huang P, Zhang WJ, Bai YX (2014) UCA1, a long non-coding RNA up-regulated in colorectal cancer influences cell proliferation, apoptosis and cell cycle distribution. Pathology. 46(5):396–401CrossRef
29.
Zurück zum Zitat Zheng Q, Wu F, Dai WY, Zheng DC, Zheng C, Ye H, Zhou B, Chen JJ, Chen P (2015) Aberrant expression of UCA1 in gastric cancer and its clinical significance. Clin Transl Oncol 17(8):640–646CrossRef Zheng Q, Wu F, Dai WY, Zheng DC, Zheng C, Ye H, Zhou B, Chen JJ, Chen P (2015) Aberrant expression of UCA1 in gastric cancer and its clinical significance. Clin Transl Oncol 17(8):640–646CrossRef
30.
Zurück zum Zitat Wang F, Ying HQ, He BS, Pan YQ, Deng QW, Sun HL, Chen J, Liu X, Wang SK (2015) Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway. Oncotarget 6(10):7899–7917CrossRef Wang F, Ying HQ, He BS, Pan YQ, Deng QW, Sun HL, Chen J, Liu X, Wang SK (2015) Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway. Oncotarget 6(10):7899–7917CrossRef
31.
Zurück zum Zitat Tian Y, Zhang X, Hao Y, Fang Z, He Y (2014) Potential roles of abnormally expressed long noncoding RNA UCA1 and Malat-1 in metastasis of melanoma. Melanoma Res 24(4):335–341CrossRef Tian Y, Zhang X, Hao Y, Fang Z, He Y (2014) Potential roles of abnormally expressed long noncoding RNA UCA1 and Malat-1 in metastasis of melanoma. Melanoma Res 24(4):335–341CrossRef
32.
Zurück zum Zitat Liu SP, Yang JX, Cao DY, Shen K (2013) Identification of differentially expressed long non-coding RNAs in human ovarian cancer cells with different metastatic potentials. Cancer Biology & Medicine 10(3):138 Liu SP, Yang JX, Cao DY, Shen K (2013) Identification of differentially expressed long non-coding RNAs in human ovarian cancer cells with different metastatic potentials. Cancer Biology & Medicine 10(3):138
33.
Zurück zum Zitat Li JY, Ma X, Zhang CB (2014) Overexpression of long non-coding RNA UCA1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma. Int J Clin Exp Pathol 7(11):7938PubMedPubMedCentral Li JY, Ma X, Zhang CB (2014) Overexpression of long non-coding RNA UCA1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma. Int J Clin Exp Pathol 7(11):7938PubMedPubMedCentral
34.
Zurück zum Zitat Wang X, Gao Z, Liao J, Shang M, Li X, Yin L, Pu Y, Liu R (2016) lncRNA UCA1 inhibits esophageal squamous-cell carcinoma growth by regulating the Wnt signaling pathway. J Toxic Environ Health A 79(9–10):407–418CrossRef Wang X, Gao Z, Liao J, Shang M, Li X, Yin L, Pu Y, Liu R (2016) lncRNA UCA1 inhibits esophageal squamous-cell carcinoma growth by regulating the Wnt signaling pathway. J Toxic Environ Health A 79(9–10):407–418CrossRef
35.
Zurück zum Zitat Jiao C, Song Z, Chen J, Zhong J, Cai W, Tian S, Chen S, Yi Y, Xiao Y (2016) lncRNA-UCA1 enhances cell proliferation through functioning as a ceRNA of Sox4 in esophageal cancer. Oncol Rep 36(5):2960–2966CrossRef Jiao C, Song Z, Chen J, Zhong J, Cai W, Tian S, Chen S, Yi Y, Xiao Y (2016) lncRNA-UCA1 enhances cell proliferation through functioning as a ceRNA of Sox4 in esophageal cancer. Oncol Rep 36(5):2960–2966CrossRef
36.
Zurück zum Zitat Deng F, Zhou K, Cui W, Liu D, Ma Y (2015) Clinicopathological significance of wnt/β-catenin signaling pathway in esophageal squamous cell carcinoma. Int J Clin Exp Pathol 8(3):3045PubMedPubMedCentral Deng F, Zhou K, Cui W, Liu D, Ma Y (2015) Clinicopathological significance of wnt/β-catenin signaling pathway in esophageal squamous cell carcinoma. Int J Clin Exp Pathol 8(3):3045PubMedPubMedCentral
Metadaten
Titel
Clinical Application of Long Non-Coding RNA-UCA1 as a Candidate Gene in Progression of Esophageal Cancer
verfasst von
Hamid Aalijahan
Saeid Ghorbian
Publikationsdatum
14.08.2019
Verlag
Springer Netherlands
Erschienen in
Pathology & Oncology Research / Ausgabe 3/2020
Print ISSN: 1219-4956
Elektronische ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-019-00711-3

Weitere Artikel der Ausgabe 3/2020

Pathology & Oncology Research 3/2020 Zur Ausgabe

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Das sind die führenden Symptome junger Darmkrebspatienten

Darmkrebserkrankungen in jüngeren Jahren sind ein zunehmendes Problem, das häufig längere Zeit übersehen wird, gerade weil die Patienten noch nicht alt sind. Welche Anzeichen Ärzte stutzig machen sollten, hat eine Metaanalyse herausgearbeitet.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.